BIODESIX INC
For the period ended Dec 31, 2023. Filed Mar 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibit and Financial Statement Schedules
(a)
Documents filed as a part of the report.
Financial Statements
Reference is made to the Index to Financial Statements of Biodesix, Inc. included in Item 8 of Part II hereof.
Financial Statement Schedules
All schedules have been omitted because they are not required, not applicable, or the required information is included in the financial statements or notes thereto.
See Item 15(b) below. Each management contract or compensating plan or arrangement required to be filed has been identified.
(b)
Exhibits.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.